Agnico Eagle
AEM
151.30
-6.94
-4.39%
Agnico Eagle
US · AEM
#215 by market cap
Listed 1970
151.30
-6.94
-4.39%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-21 07:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 6-K | 2026-11-02 | Read on SEC.gov |
| 6-K | 2026-10-28 | Read on SEC.gov |
| 6-K | 2026-09-29 | Read on SEC.gov |
| 6-K | 2026-09-09 | Read on SEC.gov |
| 6-K | 2026-08-31 | Read on SEC.gov |
| 6-K | 2026-08-24 | Read on SEC.gov |
| 6-K | 2026-08-12 | Read on SEC.gov |
| 6-K | 2026-07-30 | Read on SEC.gov |
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.98, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
✦ Quant Revenue Concentration how this is computed
Diversified
- Detour Lake is the largest reported line at 23.03% of revenue, across 10 reported segments.
- No single line clears half of revenue; Canadian Malartic is next at 18.41%, spreading the business across more than one real driver.
Revenue annual, last 8 years
Latest year +43.71% YoY
Margins
- Gross margin
- 58.13%
- Operating margin
- 53.14%
- Net margin
- 37.47%
Key ratios & quality
- Enterprise valuei
- 73.84B
- PEG ratioi
- 0.14
- Altman Z-Scorei
- 5.98
PEG uses trailing P/E against the 3-year net income growth rate (88.11%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.19B | 2.49B | 3.14B | 3.87B | 5.74B | 6.63B | 8.29B | 11.91B |
| Gross profit | 476.93M | 701.13M | 1.08B | 1.36B | 2.00B | 2.20B | 3.69B | 6.92B |
| Selling & admin expenses | 124.87M | 120.99M | 116.29M | 142.00M | 220.86M | 208.45M | 207.45M | 235.95M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 192.86M | 466.85M | 822.04M | 1.06B | 1.44B | 1.69B | 3.15B | 6.33B |
| Pretax profit | -259.05M | 738.74M | 767.57M | 932.72M | 1.12B | 2.36B | 2.82B | 6.70B |
| Tax | 67.65M | 265.58M | 255.96M | 370.78M | 445.17M | 417.76M | 925.97M | 2.24B |
| Net profit | -326.70M | 473.17M | 511.61M | 561.95M | 670.25M | 1.94B | 1.90B | 4.46B |
| Basic EPS | -1 | 2 | 2 | 2 | 2 | 4 | 4 | 9 |
| Diluted EPS | -1.40 | 1.99 | 2.10 | 2.30 | 1.53 | 3.95 | 3.78 | 8.86 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 2.82B | 3.06B | 3.56B | 4.10B | 3.80B | 3.58B |
| Gross profit | 1.65B | 1.79B | 2.20B | 2.72B | 2.43B | 2.15B |
| Selling & admin expenses | 57.89M | 67.76M | 49.59M | 77.85M | 57.95M | 69.56M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.51B | 1.64B | 2.02B | 2.56B | 2.28B | 1.99B |
| Pretax profit | 1.62B | 1.58B | 2.32B | 2.56B | 2.32B | 1.97B |
| Tax | 547.91M | 520.61M | 794.09M | 864.16M | 722.40M | 619.35M |
| Net profit | 1.07B | 1.05B | 1.52B | 1.70B | 1.60B | 1.35B |
| Basic EPS | 2 | 2 | 3 | 3 | 3 | 3 |
| Diluted EPS | 2.12 | 2.10 | 3.04 | 3.38 | 3.17 | 2.67 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.07B | 1.10B | 1.25B | 1.30B | 2.18B | 2.19B | 2.81B | 4.99B |
| Cash & ST investments | 384.44M | 337.02M | 406.46M | 191.07M | 668.52M | 348.85M | 933.74M | 2.87B |
| Inventory | 494.15M | 580.07M | 630.47M | 878.94M | 1.21B | 1.42B | 1.51B | 1.70B |
| Total assets | 7.85B | 8.79B | 9.61B | 10.22B | 23.49B | 28.68B | 29.99B | 34.47B |
| Total current liabilities | 361.45M | 775.64M | 515.70M | 761.81M | 946.42M | 1.05B | 1.51B | 2.47B |
| Short-term debt | 1.91M | 374.69M | 20.85M | 257.99M | 136.47M | 146.39M | 130.31M | 30.48M |
| Long-term debt | 1.72B | 1.36B | 1.57B | 1.34B | 1.24B | 1.74B | 1.05B | 196.27M |
| Total liabilities | 3,302,831,000.00 | 3,678,371,000.00 | 3,931,542,000.00 | 4,216,319,000.00 | 7,253,463,000.00 | 9,262,034,000.00 | 9,154,118,000.00 | 9,728,827,000.00 |
| Total equity | 4.55B | 5.11B | 5.68B | 6.00B | 16.24B | 19.42B | 20.83B | 24.74B |
| Retained earnings | -988.91M | -647.33M | -366.41M | -146.38M | -201.58M | 963.17M | 2.03B | 5.46B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 3.49B | 4.47B | 4.99B | 5.13B | 5.52B | 6.17B |
| Cash & ST investments | 1.57B | 2.35B | 2.87B | 3.12B | 3.48B | 3.63B |
| Inventory | 1.50B | 1.72B | 1.70B | 1.58B | 1.62B | 1.90B |
| Total assets | 31.69B | 32.69B | 34.47B | 35.16B | 37.80B | 39.13B |
| Total current liabilities | 1.72B | 2.11B | 2.47B | 1.63B | 1.93B | 2.24B |
| Short-term debt | 87.24M | 39.69M | 30.48M | 32.57M | 34.31M | 43.40M |
| Long-term debt | 544.61M | 195.99M | 196.27M | 196.55M | 196.83M | 197.10M |
| Total liabilities | 9,150,927,000.00 | 9,179,456,000.00 | 9,728,827,000.00 | 8,880,555,000.00 | 9,191,313,000.00 | 9,510,174,000.00 |
| Total equity | 22.54B | 23.51B | 24.74B | 26.28B | 28.60B | 29.62B |
| Retained earnings | 3.41B | 4.37B | 5.46B | 6.81B | 8.13B | 9.06B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 605.65M | 881.69M | 1.19B | 1.35B | 2.10B | 2.60B | 3.96B | 6.82B |
| Depreciation & amortization | 553.93M | 546.06M | 631.10M | 738.13M | 1.09B | 1.49B | 1.51B | 1.65B |
| Free cash flow | -483.45M | -972.00K | 432.71M | 398.31M | 558.40M | -64.13M | 2.13B | 4.26B |
| Dividends paid | -83.96M | -105.41M | -190.26M | -275.16M | -608.31M | -638.64M | -671.66M | -728.08M |
| Stock buybacks / issuance | 13.76M | 15.51M | 13.87M | -16.22M | -89.69M | -17.06M | -132.35M | -640.53M |
| Ending cash balance | 301.83M | 321.90M | 402.53M | 185.79M | 658.63M | 338.65M | 926.43M | 2.87B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.85B | 1.82B | 2.11B | 1.35B | 2.14B | 1.76B |
| Depreciation & amortization | 376.96M | 429.95M | 421.59M | 420.27M | 423.26M | 457.45M |
| Free cash flow | 1.30B | 1.19B | 1.30B | 726.84M | 1.33B | 846.77M |
| Dividends paid | -180.78M | -186.35M | -185.38M | -203.17M | -206.85M | -204.92M |
| Stock buybacks / issuance | -89.03M | -139.32M | -361.94M | -155.68M | -386.88M | -237.48M |
| Ending cash balance | 1.56B | 2.35B | 2.87B | 3.11B | 3.46B | 3.61B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -6.88 | 9.79 | 9.48 | 9.31 | 6.03 | 10.89 | 9.42 | 19.58 |
| ROA %i | -4.16 | 5.69 | 5.56 | 5.48 | 3.98 | 7.44 | 6.46 | 13.84 |
| ROIC %i | -4.18 | 7.97 | 7.87 | 7.79 | 5.51 | 10.25 | 8.91 | 18.84 |
| 5-year avg ROE %i | 0.99 | 2.46 | 4.23 | 5.42 | 5.61 | 9.16 | 9.09 | 11.11 |
| EBIT margin %i | -7.42 | 33.25 | 27.10 | 25.62 | 20.50 | 36.97 | 35.10 | 56.58 |
| FCF / sales %i | -- | -- | 13.79 | 5.55 | 9.73 | 14.13 | 25.67 | 35.79 |
| Current ratioi | 2.97 | 1.42 | 2.42 | 1.71 | 2.30 | 2.09 | 1.86 | 2.02 |
| Quick ratioi | 1.40 | 0.55 | 0.98 | 0.39 | 0.86 | 0.51 | 0.74 | 1.25 |
| Debt / assetsi | 21.94 | 20.94 | 17.53 | 16.61 | 6.36 | 6.99 | 4.28 | 0.93 |
| LT debt / equityi | 37.83 | 28.69 | 29.29 | 23.98 | 8.35 | 9.57 | 5.53 | 1.18 |
| Interest coveragei | -1.68 | 9.14 | 10.26 | 12.86 | 19.17 | 26.86 | 33.63 | 201.46 |
| Revenue CAGR (3Y) %i | 3.34 | 5.28 | 11.85 | 20.87 | 32.02 | 28.30 | 28.89 | 27.53 |
| Net income CAGR (3Y) %i | -- | 43.89 | 28.56 | -- | 12.31 | 55.97 | 49.97 | 88.11 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | 29.35 | 74.78 | 96.89 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 13.92 | 15.67 | 19.58 | 22.30 | 22.97 | 23.24 |
| ROA %i | 9.71 | 11.03 | 13.84 | 16.25 | 16.91 | 17.19 |
| ROIC %i | 13.17 | 15.18 | 18.84 | 21.45 | 22.32 | 22.71 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 46.56 | 49.50 | 56.58 | 59.79 | 60.52 | 60.98 |
| FCF / sales %i | 30.52 | 33.34 | 35.79 | 33.39 | 31.31 | 27.95 |
| Current ratioi | 2.03 | 2.12 | 2.02 | 3.15 | 2.86 | 2.75 |
| Quick ratioi | 1.00 | 1.12 | 1.25 | 2.03 | 1.90 | 1.75 |
| Debt / assetsi | 2.31 | 1.03 | 0.93 | 0.91 | 0.85 | 0.84 |
| LT debt / equityi | 2.87 | 1.26 | 1.18 | 1.09 | 1.00 | 0.96 |
| Interest coveragei | 68.57 | 85.41 | 201.46 | 302.60 | 572.15 | 1,469.20 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Detour Lake23.03%
Canadian Malartic18.41%
Meadowbank14.50%
LaRonde9.80%
Meliadine9.19%
Macassa7.47%
Kittila6.14%
Fosterville4.41%
Goldex4.06%
Other2.98%
Quote time 2026-11-20 20:02:33 · For reference only, not investment advice and not tailored to your situation.
Agnico Eagle discussion 0 comments